Name | Number of supported studies | Average coverage | |
---|---|---|---|
melanocyte | 3 studies | 43% ± 19% |
Insufficient scRNA-seq data for expression of GPR143 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 93% | 123.98 | 227 / 245 | 96% | 7.59 | 480 / 502 |
ovary | 97% | 220.82 | 175 / 180 | 82% | 11.59 | 351 / 430 |
thymus | 97% | 109.79 | 635 / 653 | 73% | 6.32 | 439 / 605 |
kidney | 100% | 358.08 | 89 / 89 | 64% | 29.38 | 578 / 901 |
uterus | 88% | 145.17 | 149 / 170 | 72% | 9.51 | 332 / 459 |
skin | 72% | 176.92 | 1298 / 1809 | 86% | 236.93 | 408 / 472 |
lung | 90% | 81.01 | 521 / 578 | 58% | 5.63 | 669 / 1155 |
pancreas | 73% | 46.40 | 240 / 328 | 66% | 5.42 | 117 / 178 |
breast | 53% | 52.21 | 241 / 459 | 76% | 8.42 | 855 / 1118 |
brain | 98% | 380.02 | 2584 / 2642 | 21% | 1.18 | 151 / 705 |
adrenal gland | 85% | 76.01 | 220 / 258 | 21% | 2.15 | 48 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 521.73 | 80 / 80 |
stomach | 42% | 24.07 | 152 / 359 | 54% | 8.92 | 155 / 286 |
bladder | 38% | 29.90 | 8 / 21 | 56% | 7.47 | 283 / 504 |
intestine | 24% | 16.85 | 229 / 966 | 64% | 9.13 | 339 / 527 |
liver | 46% | 25.87 | 103 / 226 | 34% | 3.31 | 137 / 406 |
esophagus | 38% | 58.55 | 554 / 1445 | 33% | 2.75 | 60 / 183 |
tonsil | 0% | 0 | 0 / 0 | 67% | 5.20 | 30 / 45 |
adipose | 22% | 18.40 | 268 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 1.86 | 2 / 29 |
heart | 2% | 1.28 | 18 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.56 | 13 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.47 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_1902908 | Biological process | regulation of melanosome transport |
GO_0032400 | Biological process | melanosome localization |
GO_0007165 | Biological process | signal transduction |
GO_0032438 | Biological process | melanosome organization |
GO_0032402 | Biological process | melanosome transport |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_1903056 | Biological process | regulation of melanosome organization |
GO_0006726 | Biological process | eye pigment biosynthetic process |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0033162 | Cellular component | melanosome membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0042470 | Cellular component | melanosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0035643 | Molecular function | L-DOPA receptor activity |
GO_0072544 | Molecular function | L-DOPA binding |
GO_0072545 | Molecular function | L-tyrosine binding |
GO_0035240 | Molecular function | dopamine binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GPR143 |
Protein name | G protein-coupled receptor 143 G-protein coupled receptor 143 G-protein coupled receptor 143 (Ocular albinism type 1 protein) |
Synonyms | OA1 |
Description | FUNCTION: Receptor for tyrosine, L-DOPA and dopamine. After binding to L-DOPA, stimulates Ca(2+) influx into the cytoplasm, increases secretion of the neurotrophic factor SERPINF1 and relocalizes beta arrestin at the plasma membrane; this ligand-dependent signaling occurs through a G(q)-mediated pathway in melanocytic cells. Its activity is mediated by G proteins which activate the phosphoinositide signaling pathway. Also plays a role as an intracellular G protein-coupled receptor involved in melanosome biogenesis, organization and transport. . |
Accessions | C9J9N1 P51810 A0A5J6CXI4 H7BZN6 ENST00000467482.6 A0A5J6CXM9 ENST00000431126.1 ENST00000447366.5 |